Compare Humana Inc (HUM) vs Williams-Sonoma, Inc. (WSM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Williams-Sonoma, Inc. — how do they compare? Humana Inc trades at $373.38 (market cap $46.31B), while Williams-Sonoma, Inc. trades at $250.52 (market cap $29.53B). The key difference: Humana Inc is the larger of the two by market cap, and Williams-Sonoma, Inc. pays the higher dividend (1.21%). Which is the better fit depends on your goals.
| HUM | WSM | |
|---|---|---|
Market Cap | $46.31B | $29.53B |
Sector | Health | Consumer Cyclical |
52-Week High | $409.42 | $251.81 |
52-Week Low | $163.67 | $168.64 |
Enterprise Value | $53.67B | $30.38B |
Dividend Yield | 0.92% | 1.21% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
Williams-Sonoma (WSM) trades at $251.81, up 1.94% today, near its 52-week high. The stock shows strong technical momentum with bullish moving averages, though RSI levels indicate overbought conditions. Fundamentally, the company maintains robust profitability with a 13.81% net income margin and has beaten earnings estimates for three consecutive quarters. A dividend of $0.76 is scheduled for payment in August 2026, reflecting shareholder returns.
WSM's outlook is supported by consistent earnings outperformance and high profitability metrics like 54.01% ROE. However, valuation multiples such as a P/E of 28.23 appear elevated relative to historical norms. Key risks include consumer discretionary spending volatility and competitive pressures in home furnishings. Analyst consensus is mixed with a $222.22 price target below the current price, suggesting cautious optimism amid rich valuations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Williams-Sonoma, Inc.
With a wide retail and direct-to-consumer presence, Williams-Sonoma is a leader in the $300 billion domestic home category, focused on expanding its exposure in the B2B, marketplace, and franchise areas. Namesake Williams-Sonoma (175 stores) offers high-end cooking essentials, while Pottery Barn (189) provides casual home accessories. Brand extensions include Pottery Barn Kids (52) and PBteen. West Elm (121) is an emerging concept for young professionals, and Rejuvenation (9) offers lighting and house parts. Williams-Sonoma also has a business-to-business team that supports projects that range from residential to large-scale commercial.
Read more on WSM →
